Pharma Traino

"Welcome to our Medical Representative Blog, your ultimate resource for the latest insights and strategies in the field of pharmaceutical sales. Join us as we delve into the dynamic world of medical representation, providing valuable tips, industry trends, and expert advice to help you excel in your role. Stay informed about innovative sales techniques, product knowledge, customer engagement, and effective communication skills to boost your success as a medical representative.

Post Top Ad

Your Ad Spot

Saturday, March 24, 2018

Zydus receives final approval from the USFDA for Omeprazole and Sodium Bicarbonate Capsules

VICAZydus Cadila has received the final approval from the USFDA to market Omeprazole and Sodium Bicarbonate Capsules 20 mg/1100 mg (OTC). The drug is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It is also used to prevent stomach bleeding in very ill patients. It will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad.

The group now has more than 180 approvals and has so far filed over 320 ANDAs since the commencement of the filing process in FY 2003-04.

About Zydus Cadila

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The group employs over 21,000 people worldwide and is dedicated to creating healthier communities globally. Zydus aspires to be a research-based pharmaceutical company by 2020.

No comments:

Post a Comment

Copyright 2023 And Theme By

Post Top Ad

Your Ad Spot